ERBB2 and neoplasm: Notably, the most common tumor marker expression was estrogen receptor positive (ER+), progesterone receptor positive (PR+), and human epidermal growth factor -2 negative (HER2-), with 14 patients (47%) in the Hispanic group and seven patients (64%) in the non-Hispanic group (p=0.933).